For years PBMs have been assailed by pharma companies and Congress, and the new Trump administration looks likely to keep up the barrage.

Exploring sustainable blister packaging from the lens of material selection, quality regulations, machinability, and ...

Trump emphasised the urgent need for such a defense system, stating, "We need to immediately begin the construction of a state-of-the-art iron dome missile defence shield which will be able to ...

Paul Howe, chief commercial officer at Protega Pharma, discusses recent rule changes and how the industry is impacted by them. The opioid crisis in the United States continues to cause chaos and ...

“If these institutions encounter problems, investors relying on them may face losses without the protections self-custody provides,” Bourdon said, adding: “Over the long term, those in self ...

Listed Tyneside pharmaceutical firm Shield Therapeutics has appointed a new CEO. The Gateshead drug discovery business, which specialises in iron deficiency, has announced that Anders Lundstrom has ...

The year ahead in clinical trials looks set to be one that is challenged and influenced by regulatory developments, new guidance, and broader political shifts. This month’s cover feature examines the ...

while Bahrainis face a simpler process aimed at increasing their presence in the field. Responding to MP Hisham Al Awadi, Dr Al Sayed explained that the law requires all pharmaceutical promoters — ...

The Competition Commission on Tuesday cleared the proposed amalgamation of nine entities with pharmaceutical firm Sequent Scientific Ltd (SSL). "The proposed combination involves a series of ...

Post-pandemic, health and pharma have continued to be the focus of the union government. Sources say that the finance minister is once again expected to emphasise building more primary and tertiary ...